|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
|
US4518584A
(en)
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
|
JPH0746994B2
(ja)
|
1984-10-04 |
1995-05-24 |
味の素株式会社 |
発酵法によるｌ−アミノ酸の製造法
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
CA2058820C
(en)
|
1991-04-25 |
2003-07-15 |
Kotikanyad Sreekrishna |
Expression cassettes and vectors for the secretion of human serum albumin in pichia pastoris cells
|
|
JPH07501450A
(ja)
|
1991-11-29 |
1995-02-16 |
モンサント カンパニー |
環状ジグアニレート代謝酵素
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
EP0672161B1
(en)
|
1992-11-05 |
1999-09-22 |
Xyrofin Oy |
Recombinant method and host for manufacture of xylitol
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
JP3709564B2
(ja)
|
1994-08-30 |
2005-10-26 |
味の素株式会社 |
Ｌ−バリン及びｌ−ロイシンの製造法
|
|
JP3966583B2
(ja)
|
1997-06-23 |
2007-08-29 |
協和醗酵工業株式会社 |
発酵法によるｌ−アミノ酸の製造法
|
|
US6365185B1
(en)
|
1998-03-26 |
2002-04-02 |
University Of Cincinnati |
Self-destructing, controlled release peroral drug delivery system
|
|
BR0316101A
(pt)
|
2002-11-07 |
2005-09-27 |
Immunogen Inc |
Anticorpos anticd33 e processo para tratamento de leucemia melóide aguda usando os mesmos
|
|
AU2011268498A1
(en)
|
2010-06-24 |
2013-01-31 |
Genoscience Pharma Sas |
Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
NL2006359C2
(en)
|
2011-03-08 |
2012-04-24 |
Bird Engineering B V |
Genetically modified cell and process for use of said cell.
|
|
US20130309223A1
(en)
|
2012-05-18 |
2013-11-21 |
Seattle Genetics, Inc. |
CD33 Antibodies And Use Of Same To Treat Cancer
|
|
US9913627B2
(en)
*
|
2013-01-29 |
2018-03-13 |
Becton, Dickinson And Company |
Specimen collection container having a fluid separation chamber
|
|
UY35468A
(es)
|
2013-03-16 |
2014-10-31 |
Novartis Ag |
Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
|
|
EA201691214A1
(ru)
|
2013-12-13 |
2016-12-30 |
Дженентек, Инк. |
Антитела к cd33 и иммуноконъюгаты
|
|
EP3593812A3
(en)
|
2014-03-15 |
2020-05-27 |
Novartis AG |
Treatment of cancer using chimeric antigen receptor
|
|
ES2781175T3
(es)
|
2014-07-31 |
2020-08-31 |
Novartis Ag |
Subconjunto optimizado de células T que contienen un receptor de antígeno quimérico
|
|
ES2791248T3
(es)
|
2014-08-19 |
2020-11-03 |
Novartis Ag |
Receptor antigénico quimérico (CAR) anti-CD123 para su uso en el tratamiento del cáncer
|
|
CA3197849A1
(en)
*
|
2014-12-29 |
2016-07-07 |
Novartis Ag |
Methods of making chimeric antigen receptor-expressing cells
|
|
CN113862292B
(zh)
*
|
2015-01-29 |
2024-12-27 |
明尼苏达大学董事会 |
嵌合抗原受体、组合物以及方法
|
|
US10639329B2
(en)
|
2015-06-12 |
2020-05-05 |
Lentigen Technology, Inc. |
Method to treat cancer with engineered T-cells
|
|
CN114181960B
(zh)
|
2015-10-09 |
2024-08-23 |
美天施生物科技有限公司 |
嵌合抗原受体和使用方法
|
|
AU2017208970A1
(en)
|
2016-01-18 |
2018-08-02 |
Arisan Therapeutics |
Adamatane derivatives for the treatment of filovirus infection
|
|
WO2019018185A1
(en)
|
2017-07-15 |
2019-01-24 |
Arisan Therapeutics Inc. |
ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS
|
|
US11905528B2
(en)
*
|
2017-10-12 |
2024-02-20 |
Icell Gene Therapeutics Inc. |
Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof
|
|
WO2019079339A1
(en)
|
2017-10-18 |
2019-04-25 |
Avalon Flaviviral Therapeutics (Hk) Limited |
COMPOSITIONS AND METHODS FOR BROAD SPECTRUM ANTIVIRAL THERAPY
|
|
IL321548A
(en)
*
|
2018-05-22 |
2025-08-01 |
Immunitybio Inc |
Recombinant NK cells expressing a chimeric antigen receptor (CAR) for epsilon-FC and uses thereof
|
|
WO2020055368A2
(en)
|
2018-09-12 |
2020-03-19 |
Istanbul Medipol Universitesi |
Usage of terpenic coumarin derived molecules in treating viral diseases
|
|
SG11202104287RA
(en)
*
|
2018-11-06 |
2021-05-28 |
Univ Washington |
Chimeric antigen receptor memory-like (carml) nk cells and methods of making and using same
|
|
AU2020232691B2
(en)
*
|
2019-03-05 |
2023-06-29 |
Nkarta, Inc. |
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
|
|
KR20210145179A
(ko)
*
|
2019-03-22 |
2021-12-01 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
스위치 가능한 키메라 항원 수용체-조작된 인간 자연 살해 세포
|
|
US20200308248A1
(en)
*
|
2019-03-26 |
2020-10-01 |
ST Phi Therapeutics |
Chimeric Natural Killer Cell Receptors and Method of Using Thereof
|